The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, hel** to …

During disease progression from primary towards metastatic prostate cancer (PCa), and in
particular bone metastases, the tumor microenvironment (TME) evolves in parallel with the …

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a
prostate cancer diagnosis and include management options for localized, regional …

Abstract Purpose Prostate-Specific Membrane Antigen (PSMA)-targeted Positron Emission
Tomography (PET) has revolutionised prostate cancer (PCa) diagnosis and treatment …

Prostate-specific membrane antigen PET/CT for primary staging of prostate cancer is
becoming increasingly popular due to simultaneous assessment of whole-body disease …

After prostate malignancy diagnosis, precise determination of disease extent are
fundamental steps for tailored made therapy. The earlier the diagnosis of the burden of the …

Abstract Purpose [18F] PSMA-1007 offers advantages of low urinary tracer excretion and
theoretical improved spatial resolution for imaging prostate cancer. However, non-specific …

Simple Summary Prostate cancer remains one of the leading causes of cancer death in men
worldwide. Despite the recent success in the development and clinical application of …

Prostate cancer is the second most common cancer in men worldwide.[18 F] FDG PET/CT
imaging, a well-known and effective technique for detecting malignancies, has not been …

Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …